Christopher Brown Sells Shares of 908 Devices Inc.

Christopher Brown, an insider at 908 Devices Inc. (NasdaqGM: MASS), sold 9,900 shares on June 23, 2026, at an average price of $9.04 per share. This planned transaction totaled $89,496.

What Changed in Christopher Brown's 908 Devices Inc. Position

Christopher Brown offloaded 9,900 shares of 908 Devices Inc. in a planned transaction on June 23. The shares were sold at an average price of $9.04, amounting to a total value of $89,496.

Other Institutional Activity in 908 Devices Inc.

First Light Asset Management increased its stake in 908 Devices by 1,236,377 shares, bringing its total to 6,072,563 shares valued at around $37.2 million. Needham Investment Management also boosted its position by 470,000 shares, ending with 1,240,000 shares worth approximately $7.6 million, reflecting a 61% increase. Conversely, ARK Investment Management trimmed its holdings by 39,301 shares, holding 1,946,685 shares valued at $11.9 million, a 2% decrease. BlackRock slightly reduced its position by 34,456 shares, maintaining 1,767,316 shares worth about $10.8 million.

908 Devices Inc. Stock Down 16.4%

As of Friday, shares of 908 Devices Inc. (NasdaqGM: MASS) were trading around $8.97. The company has a market capitalization of $327.5 million and a forward P/E ratio of -30.21, indicating it isn't currently profitable. The stock's 52-week range is between $5.03 and $9.34, with a 50-day moving average of $7.62 and a 200-day moving average of $6.89. The company has a current ratio of 3.58 and a quick ratio of 3.07, with a debt-to-equity ratio of 3.33.

Recent Earnings

In its most recent earnings report, 908 Devices Inc. reported revenue of $57.8 million, reflecting a growth of 13.6%. However, the company posted a net margin of -62.4% and a return on equity of -24.1%. The next earnings report is expected on August 4, 2026.

Insider Buying and Selling at 908 Devices Inc.

Besides Christopher Brown's sale, Kevin Knopp, the President and CEO, sold shares on multiple occasions, including 34,422 shares on June 23 at an average price of $9.06. Michele Leonhart, another insider, made transactions on June 25, selling 6,486 shares and also acquiring the same amount.

Analysts Set New Price Targets

Analysts have shown interest in 908 Devices Inc. On August 5, 2025, Leerink Partners upgraded the stock to a "buy" with a price target of $12. The consensus among analysts is a "buy" rating, with a mean target price of $11, based on 2 analyst opinions.

About 908 Devices Inc.

908 Devices Inc. designs and manufactures portable mass spectrometry and FTIR devices for health and safety applications. The Burlington, Massachusetts-based company, led by CEO Dr. Kevin J. Knopp, employs 172 people. Its products include handheld devices for analyzing unknown materials and detecting chemical hazards, serving markets in the U.S., Europe, the Middle East, Africa, the Asia Pacific, and the Americas.

Bottom Line

Christopher Brown's recent sale of 908 Devices shares is part of planned insider transactions, often monitored by investors for insights into company sentiment. While institutional investors have adjusted their positions, analysts maintain a positive outlook on the stock. Investors should remember that insider sales can occur for many reasons and don't necessarily indicate a negative outlook.